Old Web
English
Sign In
Acemap
>
authorDetail
>
Suzanne Parker
Suzanne Parker
University of Wollongong
Bolus (digestion)
Medicine
Physical therapy
Anesthesia
Standard treatment
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment
2019
Asia-pacific Journal of Clinical Oncology
Philip Clingan
Stephen P. Ackland
Daniel Brungs
Paul de Souza
Morteza Aghmesheh
Madhu B. Garg
Richard David Ranson
Suzanne Parker
Rebecca Jokela
Marie Ranson
Show All
Source
Cite
Save
Citations (1)
Deflexifol (a novel formulation of 5FU): Pharmacokinetics in a phase 1 trial in comparison to 5FU.
2017
Journal of Clinical Oncology
Stephen P. Ackland
Madhu B. Garg
Marie Ranson
Rebecca Jokela
Daniel Brungs
Morteza Aghmesheh
Ali Tafreshi
Richard David Ranson
Suzanne Parker
Paul de Souza
Philip Clingan
Show All
Source
Cite
Save
Citations (0)
Deflexifol (a novel formulation of 5FU): Phase 1 dose escalation study of infusional and bolus schedules after failure of standard treatment.
2017
Journal of Clinical Oncology
Philip Clingan
Stephen P. Ackland
Marie Ranson
Daniel Brungs
Morteza Aghmesheh
Ali Tafreshi
Madhu B. Garg
Suzanne Parker
Anne Henderson
Rebecca Jokela
Paul de Souza
Show All
Source
Cite
Save
Citations (0)
Phase 1 study of infusional or bolus deflexifol (a novel formulation of 5FU, folinic acid, and cyclodextrin) after failure of standard treatment.
2017
Journal of Clinical Oncology
Philip Clingan
Stephen P. Ackland
Marie Ranson
Paul de Souza
Ali Tafreshi
Morteza Aghmesheh
Daniel Brungs
Madhu B. Garg
Suzanne Parker
Rebecca Jokela
Show All
Source
Cite
Save
Citations (0)
1